ClinicalTrials.Veeva

Menu

Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity

U

University Of Perugia

Status

Unknown

Conditions

Lysosomal Acid Lipase Deficiency
Ketosis
Ketogenic Dieting
Obesity

Study type

Observational

Funder types

Other

Identifiers

NCT03564002
2017-12

Details and patient eligibility

About

The very low carbohydrates diet (VLCKD) induces liver steatosis amelioration. Lysosomal acid lipase (LAL) deficiency plays a role in fats accumulation in liver. To date, no studies have assessed LAL activity in morbid obesity. The aim of our study is to evaluate VLCKD impact on metabolic/vascular parameters and LAL activity in obese patients.

A VLCKD is administered for 25 days to 52 morbid obese patients (BMI 44.7±8.3 kg/m², age 49±12.5 years); at baseline and after diet we evaluated: BMI, glyco-lipidic pattern, abdominal ultrasonography (liver steatosis and visceral fat area) and flow-mediated dilation (FMD). In a subgroup of 20 patients we also tested lysosomal acid lipase (LAL)-activity. A group of healthy normal weight subjects (age 43±13, BMI 22.8±2.6 kg/m²) was also included in the study.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • BMI > 40 Kg/m2 or > 35 kg/m2 with comorbidities

Exclusion criteria

  • Type-2 diabetes
  • Kidney, heart or liver failure

Trial design

60 participants in 2 patient groups

obese subjects
lean subjects

Trial contacts and locations

1

Loading...

Central trial contact

Graziana Lupattelli, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems